-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BpD8hhg5d+TXHRYfaH/CmccA0iBK0rQ3H/B4GdBeFfIrzpnns4zq3t8TriYuJS72 z5qvBotzUY4Pnt+wV+sSIg== 0000936392-98-001319.txt : 19981005 0000936392-98-001319.hdr.sgml : 19981005 ACCESSION NUMBER: 0000936392-98-001319 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19981002 SROS: NONE FILER: COMPANY DATA: COMPANY CONFORMED NAME: SIGNAL PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001029201 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943174286 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-52901 FILM NUMBER: 98720254 BUSINESS ADDRESS: STREET 1: 5555 OBERLIN DR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6195587500 MAIL ADDRESS: STREET 1: 5555 OBERLIN DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 RW 1 WITHDRAWL REQUEST 1 SIGNAL PHARMACEUTICALS 5555 OBERLIN DRIVE SAN DIEGO, CA 92121 September 25, 1998 VIA EDGAR TRANSMISSION Securities and Exchange Commission 450 Fifth Street, N.W. Judiciary Plaza Washington, DC 20549 RE: SIGNAL PHARMACEUTICALS, INC. ("SIGNAL") REGISTRATION STATEMENT ON FORM S-1 (NO. 333-52901) APPLICATION FOR WITHDRAWAL Ladies and Gentlemen: The undersigned registrant hereby makes application, pursuant to paragraph (a) of Rule 477 under the Securities Act of 1933, as amended, to withdraw the above-referenced Registration Statement. This application is made on the grounds that, based on current market conditions, the undersigned registrant has determined that it is not advisable at this time to proceed with the proposed offering. If you should have any questions regarding this application, please contact Frederick T. Muto or Michael A. Newman of Cooley Godward LLP at (619) 550-6000. Sincerely, SIGNAL PHARMACEUTICALS, INC. By /s/ Alan J. Lewis Alan J. Lewis President and Chief Executive Officer cc: Mr. Bradley B. Gordon Frederick T. Muto, Esq. Michael A. Newman, Esq. -----END PRIVACY-ENHANCED MESSAGE-----